A COVID-19 colocou-nos alguns desafios difíceis, mas não deixamos que isso derrote o nosso objetivo de transformar os jovens nos líderes ambientais de amanhã.
Healio: Alpha-Gal Screening In Asymptomatic Patients Not Cost-Effective
Cost and quality-adjusted life years of alpha-gal IgE screening vs. not screening in asymptomatic patients suggest that screening is not cost-effective.